机构:[1]Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan 528400, China.[2]Guangdong Provincial Key Laboratory of Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.[3]Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
This work was supported by the Science and Technology
Development Project of Zhongshan (2020B1106).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|4 区医学
小类|4 区全科医学与补充医学
最新[2025]版:
无
第一作者:
第一作者机构:[1]Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan 528400, China.
通讯作者:
推荐引用方式(GB/T 7714):
Wu Huifei,Zhang Wenxia,Lin Hui,et al.The Pseudotargeted Metabolomics Study on the Toxicity of Fuzi Using Ultraperformance Liquid Chromatography Tandem Mass Spectrometry[J].Evidence-based complementary and alternative medicine : eCAM.2022,2022:6539675.doi:10.1155/2022/6539675.
APA:
Wu Huifei,Zhang Wenxia,Lin Hui,Ye Qiuming,Guo Jiayin&Quan Shijian.(2022).The Pseudotargeted Metabolomics Study on the Toxicity of Fuzi Using Ultraperformance Liquid Chromatography Tandem Mass Spectrometry.Evidence-based complementary and alternative medicine : eCAM,2022,
MLA:
Wu Huifei,et al."The Pseudotargeted Metabolomics Study on the Toxicity of Fuzi Using Ultraperformance Liquid Chromatography Tandem Mass Spectrometry".Evidence-based complementary and alternative medicine : eCAM 2022.(2022):6539675